HER2-IN-6
Margetuximab
Ponezumab
Zalutumumab
DHFR-IN-4
Lys-Arg-Thr-Leu-Arg-Arg
Lumretuzumab
Intetumumab
Imgatuzumab
Seribantumab
Nelipepimut-S
Zenocutuzumab
Barecetamab
Bafisontamab
Anbenitamab
Petosemtamab
Zanidatamab
Tomuzotuximab
Timigutuzumab
Gancotamab